Cameron Joyce MPA

Cameron Joyce is a Senior Policy Analyst at the Duke-Margolis Institute for Health Policy.

He contributes to the Institute’s Biomedical Innovation and Evidence Development portfolio, with a focus on digital health, artificial intelligence (AI) governance and safety, and drug supply chain resilience, including efforts in advanced manufacturing and to address drug shortages. His work also supports policy research combating drug-resistant infections and antimicrobial resistance (AMR), as well as initiatives to advance clinical trials.

Cameron has extensive experience collaborating with the U.S. Food and Drug Administration (FDA) through joint research and convenings aimed at strengthening regulatory science and advancing the efficient development of safe and effective drugs and medical products.